Patents by Inventor Daniela Daubert

Daniela Daubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220411466
    Abstract: The present invention relates to a method for increasing antibody yield during antibody purification from a sample by ion exchange chromatography in flow-through mode by pre-conditioning the sample with Tris without the use of NaCl to adjust the conductivity.
    Type: Application
    Filed: November 20, 2020
    Publication date: December 29, 2022
    Inventors: Daniela DAUBERT, Dominik GELTINGER, Karin FELDERER
  • Publication number: 20220411465
    Abstract: The present invention relates to an improved method for peak fractionation and eluate collection during chromatography for purification of a human therapeutic antibody.
    Type: Application
    Filed: November 20, 2020
    Publication date: December 29, 2022
    Inventors: Daniela DAUBERT, Dominik GELTINGER, Karin FELDERER
  • Patent number: 10273285
    Abstract: The present disclosure relates to fusion proteins that are highly useful for the generation of virus-like particles for the display of membrane spanning proteins. Related embodiments, methods and uses are disclosed.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: April 30, 2019
    Assignee: MORPHOSYS AG
    Inventors: Sebastian Jaeger, Daniela Daubert, Kathrin Goetz
  • Patent number: 9689014
    Abstract: The present disclosure provides a method to express and purify polypeptides and proteins. In the present disclosure the use of lysozyme as a fusion partner is disclosed. Furthermore, purification methods to isolate lysozyme-tagged polypeptides and proteins via lysozyme-specific antibodies are described. More specifically, the present disclosure provides a method to express and purify monomeric polypeptides and proteins by using lysozyme as a tag.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: June 27, 2017
    Assignee: MORPHOSYS AG
    Inventors: Stefan Haertle, Sebastian Jaeger, Daniela Daubert
  • Publication number: 20170121388
    Abstract: The present disclosure relates to fusion proteins that are highly useful for the generation of virus-like particles for the display of membrane spanning proteins. Related embodiments, methods and uses are disclosed.
    Type: Application
    Filed: June 9, 2015
    Publication date: May 4, 2017
    Inventors: Sebastian Jaeger, Daniela Daubert, Kathrin Goetz
  • Patent number: 9115390
    Abstract: The present invention relates to a method for identifying frameshift mutations in coding nucleic acid sequences.
    Type: Grant
    Filed: March 1, 2010
    Date of Patent: August 25, 2015
    Assignee: GeneArt AG
    Inventors: Michael Liss, Jutta Derer, Frank Notka, Daniela Daubert, Claudia Benkel
  • Publication number: 20140349343
    Abstract: The present disclosure provides a method to express and purify polypeptides and proteins. In the present disclosure the use of lysozyme as a fusion partner is disclosed. Furthermore, purification methods to isolate lysozyme-tagged polypeptides and proteins via lysozyme-specific antibodies are described. More specifically, the present disclosure provides a method to express and purify monomeric polypeptides and proteins by using lysozyme as a tag.
    Type: Application
    Filed: January 23, 2013
    Publication date: November 27, 2014
    Inventors: Stefan Haertle, Sebastian Jaeger, Daniela Daubert
  • Publication number: 20100297642
    Abstract: The present invention relates to a method for identifying frameshift mutations in coding nucleic acid sequences.
    Type: Application
    Filed: March 1, 2010
    Publication date: November 25, 2010
    Applicant: GENEART AG
    Inventors: Michael Liss, Jutta Derer, Frank Notka, Daniela Daubert, Claudia Benkel